Nohla Therapeutics Announces Closing of $43.5M Series A Financing to Transform Stem Cell Transplantation with Innovative Off the Shelf, Universal Donor Cellular Therapy
29. November 2016 05:30 ET
|
Nohla Therapeutics
SEATTLE, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a biotechnology company pioneering the field of universal donor cellular therapies for treating patients with life...